Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07636174 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Screening Preventive Reminder Ordering AssistanCe Via Texting for Improved Visit Encounters
A NA study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- NA
- Development phase
- 3,888
- Enrollment target
NCT07636174: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT07636174 is a NA study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 3,888 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (177% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07636174, a NA study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 3,888 participants
- Enrollment target
Study Summary
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. A substantial portion of the United States population remains overdue for screening, despite availability and insurance coverage of preventive health services. Barriers for completion and remaining up to date with screening include patients not remaining actively engaged with their care team, time constraints during office visits, and operational strain. This project aims to implement and evaluate a primary care visit-based outreach program that improves patient follow through on completion of overdue CRC screening. This will be a 6 month, stepped-wedge, pragmatic trial conducted at Penn Medicine.
Interventions
- BEHAVIORAL Post-visit patient messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,888 participants |
| Start Date | 2026-06-08 |
| Est. Completion | 2027-05-23 |
| Phase | NA |
What is known before NCT07636174 opens enrollment
NCT07636174 is an interventional study that assigns participants to a tested intervention. Its 3,888 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (177% higher).
The record links to 0 conditions, and to 1 intervention - of which Post-visit patient messaging is the first listed.
NCT07636174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07636174 about?
NCT07636174 is a clinical study titled "Colorectal Cancer Screening Preventive Reminder Ordering AssistanCe Via Texting for Improved Visit Encounters". Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. A substantial portion of the United States population remains overdue for screening, despite availability and insurance coverage of preventive health services. Barriers for completion and remaining up to date w...
What is the current status of trial NCT07636174?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 3,888 participants. The study started on 2026-06-08. Estimated completion is 2027-05-23.
What interventions are being tested in trial NCT07636174?
The interventions under investigation include: Post-visit patient messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT07636174?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07636174's enrollment target sits among peer trials
3,888 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI